Aktie A2DW3Z VITA LIFE SCIENCES LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Vita Life Sciences Limited

Aktien

A2DW3Z

AU000000VLS8

VLS

Markt geschlossen - Australian S.E.
Andere Börsenplätze
 05:33:55 28.06.2024 		% 5 Tage % 1. Jan.
2.28 AUD -.--% Intraday Chart für Vita Life Sciences Limited -4.20% +28.09%
14.06. Vita Life Sciences gibt H1 Umsatzprognose von AU$39 Millionen bis AU$40 Millionen heraus MT
13.06. Vita Life Sciences Limited gibt Gewinnprognose für das Halbjahr bis 30. Juni 2024 ab CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Vita Life Sciences Issues H1 Sales Guidance of AU$39 Million to AU$40 Million
Vita Life Sciences Limited Provides Earnings Guidance for Half Year Ending June 30, 2024
Vita Life Sciences Limited announces an Equity Buyback for 8,361,571 shares, representing 15% of its issued share capital.
Vita Life Sciences Limited authorizes a Buyback Plan.
Vita Life Sciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Vita Life Sciences Limited Provides Earnings Guidance for the Full Year Ending December 31, 2023
Vita Life Sciences Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, 6 October 2023
Vita Life Sciences Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Vita Life Sciences Limited Appoints Peter Osborne as an Independent Non-Executive Director
Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending 30 June 2023
Vita Life Sciences Limited announces an Equity Buyback for 8,475,692 shares, representing 15% of its issued share capital.
Vita Life Sciences Limited's Equity Buyback announced on May 11, 2022, has expired with 208,000 shares, representing 0.37% for AUD 0.34 million.
Vita Life Sciences Limited authorizes a Buyback Plan.
Vita Life Sciences Limited Announces Demise of Gregory Ralph, Non-Executive Director
Vita Life Sciences Limited Announces Dividend for Six Months Ended December 31, 2022, Payable on April 14, 2023
Vita Life Sciences Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Vita Life Sciences Provides Earnings Guidance for the Full Year Ending 31 December 2022
Vita Life Sciences Limited Announces Board Changes, Effective 30 September 2022
Vita Life Sciences Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Vita Life Sciences Limited Declares Fully Franked Interim Dividend for the Six Months Ended June 30, 2022, Payable on 7 October 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2DW3Z Aktie
  4. Nachrichten Vita Life Sciences Limited
  5. Andere Sprachen